Abstract
Post-cardiotomy cardiogenic shock (PCS) is an infrequent occurrence reported from 3-5%. Where inotropic support and intra-aortic balloon pump fail to resuscitate the patient, VA-ECMO is the next step to avert certain death (0.5-3%) [ [1] Khorsandi M. Dougherty S. Bouamra O. Pai V. Curry P. Tsui S. et al. Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Surg. 2017; 12: 55 Crossref PubMed Scopus (90) Google Scholar ]. Survival from PCS-ECMO has been reported to range from 24%-42%. This study’s purpose was to determine survival in PCS-ECMO in the Australia/New Zealand populations, and identify adverse prognostic indicators (APIs) to ensure better selection of patients in the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
